000 01862 a2200553 4500
005 20250513165125.0
264 0 _c19990303
008 199903s 0 0 eng d
022 _a0950-9232
024 7 _a10.1038/sj.onc.1202421
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSala, A
245 0 0 _aB-MYB transactivates its own promoter through SP1-binding sites.
_h[electronic resource]
260 _bOncogene
_cFeb 1999
300 _a1333-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenovirus E1A Proteins
_xmetabolism
650 0 4 _aBinding Sites
650 0 4 _aCell Cycle Proteins
650 0 4 _aCell Line
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aFungal Proteins
_xgenetics
650 0 4 _aHerpes Simplex Virus Protein Vmw65
_xmetabolism
650 0 4 _aHumans
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aOligonucleotides
_xpharmacology
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aProtein Binding
650 0 4 _aProto-Oncogene Proteins
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-myb
650 0 4 _aRecombinant Fusion Proteins
650 0 4 _aSaccharomyces cerevisiae Proteins
650 0 4 _aSp1 Transcription Factor
_xgenetics
650 0 4 _aSp3 Transcription Factor
650 0 4 _aTrans-Activators
_xgenetics
650 0 4 _aTranscription Factors
_xgenetics
650 0 4 _aTranscription, Genetic
650 0 4 _aTranscriptional Activation
_xdrug effects
650 0 4 _aTransfection
700 1 _aSaitta, B
700 1 _aDe Luca, P
700 1 _aCervellera, M N
700 1 _aCasella, I
700 1 _aLewis, R E
700 1 _aWatson, R
700 1 _aPeschle, C
773 0 _tOncogene
_gvol. 18
_gno. 6
_gp. 1333-9
856 4 0 _uhttps://doi.org/10.1038/sj.onc.1202421
_zAvailable from publisher's website
999 _c9984178
_d9984178